The intricate connection between diet, microbiota, and cancer: A jigsaw puzzle

Seminars in Immunology

Volumn 32, Issue , 2017, Pages 35-42

  Arkan, Melek Canan ^a,b,c  

^a GOETHE UNIVERSITY   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

BACTERIUM; CANCER THERAPY; DIET; DRUG INDUSTRY; FECES MICROFLORA; HEALTH; HUMAN; INCOME; INTESTINE FLORA; MALIGNANT NEOPLASM; MICROBIAL COMMUNITY; NONHUMAN; NUTRITION; PERSONALIZED MEDICINE; REVIEW; ANIMAL; GENOTYPE ENVIRONMENT INTERACTION; HOST PATHOGEN INTERACTION; IMMUNITY; IMMUNOLOGY; MICROBIOLOGY; NEOPLASM; SYMBIOSIS;

ANIMALS; DIET; GASTROINTESTINAL MICROBIOME; GENE-ENVIRONMENT INTERACTION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; NEOPLASMS; SYMBIOSIS;

EID: 85028589366     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2017.08.009     Document Type: Review

References (146)

1. Ley, R.E., Peterson, D.A., Gordon, J.I., Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124:4 (2006), 837–848, 10.1016/j.cell.2006.02.017.
2. Gill, S.R., Pop, M., Deboy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., Nelson, K.E., Metagenomic analysis of the human distal gut microbiome. Science 312:5778 (2006), 1355–1359, 10.1126/science.1124234.
3. Backhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., Gordon, J.I., Host-bacterial mutualism in the human intestine. Science 307:5717 (2005), 1915–1920, 10.1126/science.1104816.
4. Gomez de Aguero, M., Ganal-Vonarburg, S.C., Fuhrer, T., Rupp, S., Uchimura, Y., Li, H., Macpherson, A.J., The maternal microbiota drives early postnatal innate immune development. Science 351:6279 (2016), 1296–1302, 10.1126/science.aad2571.
5. Hansen, C.H., Metzdorff, S.B., Hansen, A.K., Customizing laboratory mice by modifying gut microbiota and host immunity in an early window of opportunity. Gut Microbes 4:3 (2013), 241–245, 10.4161/gmic.23999.
6. Chu, D.M., Ma, J., Prince, A.L., Antony, K.M., Seferovic, M.D., Aagaard, K.M., Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat. Med. 23:3 (2017), 314–326, 10.1038/nm.4272.
7. Flint, H.J., Scott, K.P., Duncan, S.H., Louis, P., Forano, E., Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3:4 (2012), 289–306, 10.4161/gmic.19897.
8. Smith, K., McCoy, K.D., Macpherson, A.J., Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin. Immunol. 19:2 (2007), 59–69, 10.1016/j.smim.2006.10.002.
9. Round, J.L., Mazmanian, S.K., The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9:5 (2009), 313–323, 10.1038/nri2515.
10. Beura, L.K., Hamilton, S.E., Bi, K., Schenkel, J.M., Odumade, O.A., Casey, K.A., Masopust, D., Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532:7600 (2016), 512–516, 10.1038/nature17655.
11. Monda, V., Villano, I., Messina, A., Valenzano, A., Esposito, T., Moscatelli, F., Messina, G., Exercise modifies the gut microbiota with positive health effects. Oxid. Med. Cell. Longev., 3831972, 2017 (10.1155/2017/3831972).
12. Lassi, Z.S., Mansoor, T., Salam, R.A., Bhutta, S.Z., Das, J.K., Bhutta, Z.A.1, Review of nutrition guidelines relevant for adolescents in low- and middle-income countries. Ann. N. Y. Acad. Sci. 1393:1 (2017), 51–60, 10.1111/nyas.13332.
13. Bashan, A., Gibson, T.E., Friedman, J., Carey, V.J., Weiss, S.T., Hohmann, E.L., Liu, Y.Y., Universality of human microbial dynamics. Nature 534:7606 (2016), 259–262, 10.1038/nature18301.
14. Blanton, L.V., Barratt, M.J., Charbonneau, M.R., Ahmed, T., Gordon, J.I., Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics. Science, 352(6293), 2016, 1533, 10.1126/science.aad9359.
15. Blanton, L.V., Charbonneau, M.R., Salih, T., Barratt, M.J., Venkatesh, S., Ilkaveya, O., Gordon, J.I., Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science, 351(6275), 2016, 10.1126/science.aad3311.
16. Charbonneau, M.R., O'Donnell, D., Blanton, L.V., Totten, S.M., Davis, J.C., Barratt, M.J., Gordon, J.I., Sialylated milk oligosaccharides promote microbiota-Dependent growth in models of infant undernutrition. Cell 164:5 (2016), 859–871, 10.1016/j.cell.2016.01.024.
17. Wexler, A.G., Bao, Y., Whitney, J.C., Bobay, L.M., Xavier, J.B., Schofield, W.B., Goodman, A.L., Human symbionts inject and neutralize antibacterial toxins to persist in the gut. Proc. Natl. Acad. Sci. U. S. A. 113:13 (2016), 3639–3644, 10.1073/pnas.1525637113.
18. Wagner, V.E., Dey, N., Guruge, J., Hsiao, A., Ahern, P.P., Semenkovich, N.P., Gordon, J.I., Effects of a gut pathobiont in a gnotobiotic mouse model of childhood undernutrition. Sci. Transl. Med., 2016, a164, 10.1126/scitranslmed.aah4669.
19. Asano, Y., Hiramoto, T., Nishino, R., Aiba, Y., Kimura, T., Yoshihara, K., Sudo, N., Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am. J. Physiol. Gastrointest. Liver Physiol. 303:11 (2012), G1288–1295, 10.1152/ajpgi.00341.2012.
20. Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., Hsiao, E.Y., Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161:2 (2015), 264–276, 10.1016/j.cell.2015.02.047.
21. Donohoe, D.R., Holley, D., Collins, L.B., Montgomery, S.A., Whitmore, A.C., Hillhouse, A., Bultman, S.J., A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov. 4:12 (2014), 1387–1397, 10.1158/2159-8290 (CD-14-0501).
22. Nastasi, C., Candela, M., Bonefeld, C.M., Geisler, C., Hansen, M., Krejsgaard, T., Woetmann, A., The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci. Rep., 5, 2015, 16148, 10.1038/srep16148.
23. Lynch, J.P., Sikder, M.A., Curren, B.F., Werder, R.B., Simpson, J., Cuiv, P.O., Phipps, S., The influence of the microbiome on early-Life severe viral lower respiratory infections and asthma-Food for thought?. Front. Immunol., 8, 2017, 156, 10.3389/fimmu.2017.00156.
24. Schuijt, T.J., Lankelma, J.M., Scicluna, B.P., de Sousa e Melo, F., Roelofs, J.J., de Boer, J.D., Wiersinga, W.J., The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 65:4 (2016), 575–583, 10.1136/gutjnl-2015-309728.
25. Julia, V., Macia, L., Dombrowicz, D., The impact of diet on asthma and allergic diseases. Nat. Rev. Immunol. 15:5 (2015), 308–322, 10.1038/nri3830.
26. Berer, K., Mues, M., Koutrolos, M., Rasbi, Z.A., Boziki, M., Johner, C., Krishnamoorthy, G., Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479:7374 (2011), 538–541, 10.1038/nature10554.
27. Kriegel, M.A., Sefik, E., Hill, J.A., Wu, H.J., Benoist, C., Mathis, D., Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 108:28 (2011), 11548–11553, 10.1073/pnas.1108924108.
28. Tilg, H., Kaser, A., Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Invest. 121:6 (2011), 2126–2132, 10.1172/JCI58109.
29. Soyucen, E., Gulcan, A., Aktuglu-Zeybek, A.C., Onal, H., Kiykim, E., Aydin, A., Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatr. Int. 56:3 (2014), 336–343, 10.1111/ped.12243.
30. Ait-Belgnaoui, A., Han, W., Lamine, F., Eutamene, H., Fioramonti, J., Bueno, L., Theodorou, V., Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction. Gut 55:8 (2006), 1090–1094, 10.1136/gut.2005.084194.
31. Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Desreumaux, P., Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 13:1 (2007), 35–37, 10.1038/nm1521.
32. Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13:10 (2012), 701–712, 10.1038/nrn3346.
33. de Theije, C.G., Wu, J., Koelink, P.J., Korte-Bouws, G.A., Borre, Y., Kas, M.J., Kraneveld, A.D., Autistic-like behavioural and neurochemical changes in a mouse model of food allergy. Behav. Brain Res. 261 (2014), 265–274, 10.1016/j.bbr.2013.12.008.
34. Benakis, C., Brea, D., Caballero, S., Faraco, G., Moore, J., Murphy, M., Anrather, J., Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat. Med. 22:5 (2016), 516–523, 10.1038/nm.4068.
35. Winek, K., Engel, O., Koduah, P., Heimesaat, M.M., Fischer, A., Bereswill, S., Dirnagl, U., Depletion of cultivatable gut microbiota by broad-Spectrum antibiotic pretreatment worsens outcome after murine stroke. Stroke 47:5 (2016), 1354–1363, 10.1161/STROKEAHA.115.011800.
36. Spadoni, I., Zagato, E., Bertocchi, A., Paolinelli, R., Hot, E., Di Sabatino, A., Rescigno, M., A gut-vascular barrier controls the systemic dissemination of bacteria. Science 350:6262 (2015), 830–834, 10.1126/science.aad0135.
37. Hawrelak, J.A., Myers, S.P., The causes of intestinal dysbiosis: a review. Altern. Med. Rev. 9:2 (2004), 180–197.
38. Grivennikov, S.I., Wang, K., Mucida, D., Stewart, C.A., Schnabl, B., Jauch, D., Karin, M., Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491:7423 (2012), 254–258, 10.1038/nature11465.
39. Desai, M.S., Seekatz, A.M., Koropatkin, N.M., Kamada, N., Hickey, C.A., Wolter, M., Martens, A dietary fiber-Deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167:5 (2016), 1339–1353, 10.1016/j.cell.2016.10.043 (e1321).
40. Duffin, R., O'Connor, R.A., Crittenden, S., Forster, T., Yu, C., Zheng, X., Yao, C., Prostaglandin E(2) constrains systemic inflammation through an innate lymphoid cell-IL-22 axis. Science 351:6279 (2016), 1333–1338, 10.1126/science.aad9903.
41. Genton, L., Cani, P.D., Schrenzel, J., Alterations of gut barrier and gut microbiota in food restriction, food deprivation and protein-energy wasting. Clin. Nutr. 34:3 (2015), 341–349, 10.1016/j.clnu.2014.10.003.
42. Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 102:31 (2005), 11070–11075, 10.1073/pnas.0504978102.
43. Marchesi, J.R., Adams, D.H., Fava, F., Hermes, G.D., Hirschfield, G.M., Hold, G., Hart, A., The gut microbiota and host health: a new clinical frontier. Gut 65:2 (2016), 330–339, 10.1136/gutjnl-2015-309990.
44. Schulz, M.D., Atay, C., Heringer, J., Romrig, F.K., Schwitalla, S., Aydin, B., Arkan, M.C., High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature 514:7523 (2014), 508–512, 10.1038/nature13398.
45. Arthur, J.C., Perez-Chanona, E., Muhlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T.J., Jobin, C., Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338:6103 (2012), 120–123, 10.1126/science.1224820.
46. Kang, M., Martin, A., Microbiome and colorectal cancer: unraveling host-microbiota interactions in colitis-associated colorectal cancer development. Semin. Immunol., 2017, 10.1016/j.smim.2017.04.003.
47. Zackular, J.P., Rogers, M.A., Ruffin, M. T. t., Schloss, P.D., The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev. Res. (Phila) 7:11 (2014), 1112–1121, 10.1158/1940-6207 (CAPR-14-0129).
48. Nakatsu, G., Li, X., Zhou, H., Sheng, J., Wong, S.H., Wu, W.K., Sung, J.J., Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat. Commun., 6, 2015, 8727, 10.1038/ncomms9727.
49. Wu, N., Yang, X., Zhang, R., Li, J., Xiao, X., Hu, Y., Zhu, Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb. Ecol. 66:2 (2013), 462–470, 10.1007/s00248-013-0245-9.
50. Sears, C.L., Pardoll, D.M., Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J. Infect. Dis. 203:3 (2011), 306–311, 10.1093/jinfdis/jiq061.
51. Hajishengallis, G., Darveau, R.P., Curtis, M.A., The keystone-pathogen hypothesis. Nat. Rev. Microbiol. 10:10 (2012), 717–725, 10.1038/nrmicro2873.
52. Tjalsma, H., Boleij, A., Marchesi, J.R., Dutilh, B.E., A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol. 10:8 (2012), 575–582, 10.1038/nrmicro2819.
53. Warren, R.L., Freeman, D.J., Pleasance, S., Watson, P., Moore, R.A., Cochrane, K., Holt, R.A., Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome, 1(1), 2013, 16, 10.1186/2049-2618-1-16.
54. Wang, X., Yang, Y., Huycke, M.M., Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect. Gut 64:3 (2015), 459–468, 10.1136/gutjnl-2014-307213.
55. Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Zhao, Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6:2 (2012), 320–329, 10.1038/ismej.2011.109.
56. Lu, Y., Chen, J., Zheng, J., Hu, G., Wang, J., Huang, C., Zeng, Y., Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas. Sci. Rep., 6(26337), 2016, 10.1038/srep26337.
57. Pagnini, C., Corleto, V.D., Mangoni, M.L., Pilozzi, E., Torre, M.S., Marchese, R., Delle Fave, G., Alteration of local microflora and alpha-defensins hyper-production in colonic adenoma mucosa. J. Clin. Gastroenterol. 45:7 (2011), 602–610, 10.1097/MCG.0b013e31820abf29.
58. Boleij, A., Tjalsma, H., The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease. Lancet Infect. Dis. 13:8 (2013), 719–724, 10.1016/S1473-3099(13)70107-5.
59. Prorok-Hamon, M., Friswell, M.K., Alswied, A., Roberts, C.L., Song, F., Flanagan, P.K., Campbell, B.J., Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut 63:5 (2014), 761–770, 10.1136/gutjnl-2013-304739.
60. Rubinstein, M.R., Wang, X., Liu, W., Hao, Y., Cai, G., Han, Y.W., Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14:2 (2013), 195–206, 10.1016/j.chom.2013.07.012.
61. Lu, R., Wu, S., Zhang, Y.G., Xia, Y., Liu, X., Zheng, Y., Sun, J., Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway. Oncogenesis, 3, 2014, e105, 10.1038/oncsis.2014.20.
62. O'Keefe, S.J., Diet, microorganisms and their metabolites, and colon cancer. Nat. Rev. Gastroenterol. Hepatol. 13:12 (2016), 691–706, 10.1038/nrgastro.2016.165.
63. Bultman, S.J., Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer. Mol. Nutr. Food Res., 61(1), 2017, 10.1002/mnfr.201500902.
64. Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Rudensky, Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504:7480 (2013), 451–455, 10.1038/nature12726.
65. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Ohno, H., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:7480 (2013), 446–450, 10.1038/nature12721.
66. Donohoe, D.R., Garge, N., Zhang, X., Sun, W., O'Connell, T.M., Bunger, M.K., Bultman, S.J., The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 13:5 (2011), 517–526, 10.1016/j.cmet.2011.02.018.
67. Donohoe, D.R., Collins, L.B., Wali, A., Bigler, R., Sun, W., Bultman, S.J., The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 48:4 (2012), 612–626, 10.1016/j.molcel.2012.08.033.
68. Chang, P.V., Hao, L., Offermanns, S., Medzhitov, R., The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. U. S. A. 111:6 (2014), 2247–2252, 10.1073/pnas.1322269111.
69. Bultman, S.J., Jobin, C., Microbial-derived butyrate: an oncometabolite or tumor-suppressive metabolite?. Cell Host Microbe 16:2 (2014), 143–145, 10.1016/j.chom.2014.07.011.
70. Belcheva, A., Irrazabal, T., Robertson, S.J., Streutker, C., Maughan, H., Rubino, S., Martin, A., Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 158:2 (2014), 288–299, 10.1016/j.cell.2014.04.051.
71. Brito, I.L., Yilmaz, S., Huang, K., Xu, L., Jupiter, S.D., Jenkins, A.P., Alm, E.J., Mobile genes in the human microbiome are structured from global to individual scales. Nature 535:7612 (2016), 435–439, 10.1038/nature18927.
72. O'Keefe, S.J., Li, J.V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Zoetendal, E.G., Fat, fibre and cancer risk in African Americans and rural Africans. Nat. Commun., 6, 2015, 6342, 10.1038/ncomms7342.
73. Devkota, S., Wang, Y., Musch, M.W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Chang, E.B., Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487:7405 (2012), 104–108, 10.1038/nature11225.
74. Yazici, C., Wolf, P.G., Kim, H., Cross, T.L., Vermillion, K., Carroll, T., Gaskins, Race-dependent association of sulfidogenic bacteria with colorectal cancer. Gut, 2017, 10.1136/gutjnl-2016-313321.
75. Cerletti, M., Jang, Y.C., Finley, L.W., Haigis, M.C., Wagers, A.J., Short-term calorie restriction enhances skeletal muscle stem cell function. Cell Stem Cell 10:5 (2012), 515–519, 10.1016/j.stem.2012.04.002.
76. Rodriguez-Colman, M.J., Schewe, M., Meerlo, M., Stigter, E., Gerrits, J., Pras-Raves, M., Burgering, B.M., Interplay between metabolic identities in the intestinal crypt supports stem cell function. Nature 543:7645 (2017), 424–427, 10.1038/nature21673.
77. Yilmaz, O.H., Katajisto, P., Lamming, D.W., Gultekin, Y., Bauer-Rowe, K.E., Sengupta, S., Sabatini, D.M., mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature 486:7404 (2012), 490–495, 10.1038/nature11163.
78. Beyaz, S., Mana, M.D., Roper, J., Kedrin, D., Saadatpour, A., Hong, S.J., Yilmaz, O.H., High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature 531:7592 (2016), 53–58, 10.1038/nature17173.
79. Piper, M.D., Partridge, L., Raubenheimer, D., Simpson, S.J., Dietary restriction and aging: a unifying perspective. Cell Metab. 14:2 (2011), 154–160, 10.1016/j.cmet.2011.06.013.
80. Di Biase, S., Lee, C., Brandhorst, S., Manes, B., Buono, R., Cheng, C.W., Longo, V.D., Fasting-Mimicking diet reduces HO-1 to promote t cell-Mediated tumor cytotoxicity. Cancer Cell 30:1 (2016), 136–146, 10.1016/j.ccell.2016.06.005.
81. Zhang, C., Li, S., Yang, L., Huang, P., Li, W., Wang, S., Zhao, L., Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat. Commun., 4, 2013, 2163, 10.1038/ncomms3163.
82. Hooper, L.V., Midtvedt, T., Gordon, J.I., How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22 (2002), 283–307, 10.1146/annurev.nutr.22.011602.092259.
83. Bozena, D.K., Iwona, D., Ilona, K., The mycobiome – a friendly cross-talk between fungal colonizers and their host. Ann. Parasitol. 62:3 (2016), 175–184.
84. Moore, P.S., Chang, Y., Common commensal cancer viruses. PLoS Pathog., 13(1), 2017, e1006078, 10.1371/journal.ppat.1006078.
85. Gasbarrini, G., Bonvicini, F., Gramenzi, A., Probiotics history. J clin gastroenterol, 50 suppl 2. Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health Meeting Held in Rome, Italy on September, 2016, 13–15 (S116-S119. 10.1097/MCG.0000000000000697 2015).
86. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Sanders, M.E., Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11:8 (2014), 506–514, 10.1038/nrgastro.2014.66.
87. Rondanelli, M., Faliva, M.A., Perna, S., Giacosa, A., Peroni, G., Castellazzi, A.M., Using probiotics in clinical practice: where are we now? A review of existing meta-analyses. Gut Microbes, 2017, 0, 10.1080/19490976.2017.1345414.
88. Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K.M., Brigidi, P., Campieri, M., Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124:5 (2003), 1202–1209.
89. Shen, J., Zuo, Z.X., Mao, A.P., Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm. Bowel Dis. 20:1 (2014), 21–35, 10.1097/01. MIB.0000437495.30052 (be).
90. Arthur, J.C., Gharaibeh, R.Z., Uronis, J.M., Perez-Chanona, E., Sha, W., Tomkovich, S., Jobin, C., VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci. Rep., 3, 2013, 2868, 10.1038/srep02868.
91. Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Honda, K., Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500:7461 (2013), 232–236, 10.1038/nature12331.
92. Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., Cryan, J.F., Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U. S. A. 108:38 (2011), 16050–16055, 10.1073/pnas.1102999108.
93. Yang, Y., Xia, Y., Chen, H., Hong, L., Feng, J., Yang, J., Ma, Y., The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial. Oncotarget 7:7 (2016), 8432–8440, 10.18632/oncotarget.7045.
94. Jeppsson, B., Mangell, P., Thorlacius, H., Use of probiotics as prophylaxis for postoperative infections. Nutrients 3:5 (2011), 604–612, 10.3390/nu3050604.
95. Delia, P., Sansotta, G., Donato, V., Frosina, P., Messina, G., De Renzis, C., Famularo, G., Use of probiotics for prevention of radiation-induced diarrhea. World J. Gastroenterol. 13:6 (2007), 912–915.
96. Berretta, M., Della Pepa, C., Tralongo, P., Fulvi, A., Martellotta, F., Lleshi, A., Facchini, Use of complementary and alternative medicine (CAM) in cancer patients: an italian multicenter survey. Oncotarget, 2016, 10.18632/oncotarget.14224.
97. Ciernikova, S., Mego, M., Semanova, M., Wachsmannova, L., Adamcikova, Z., Stevurkova, V., Zajac, V., Probiotic survey in cancer patients treated in the outpatient department in a comprehensive cancer center. Integr. Cancer Ther., 2016, 10.1177/1534735416643828.
98. Abt, M.C., McKenney, P.T., Pamer, E.G., Clostridium difficile colitis: pathogenesis and host defence. Nat. Rev. Microbiol. 14:10 (2016), 609–620, 10.1038/nrmicro.2016.108.
99. McKenney, P.T., Pamer, E.G., From hype to hope: the gut microbiota in enteric infectious disease. Cell 163:6 (2015), 1326–1332, 10.1016/j.cell.2015.11.032.
100. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., de Vos, W.M., Keller, J.J., Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368:5 (2013), 407–415, 10.1056/NEJMoa1205037.
101. Theriot, C.M., Koenigsknecht, M.J., Carlson, P.E. Jr., Hatton, G.E., Nelson, A.M., Li, B., Young, V.B., Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun., 5, 2014, 3114, 10.1038/ncomms4114.
102. Buffie, C.G., Bucci, V., Stein, R.R., McKenney, P.T., Ling, L., Gobourne, A., Pamer, E.G., Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517:7533 (2015), 205–208, 10.1038/nature13828.
103. Lee, Y.J., Arguello, E.P., Jenq, R.R., Littmann, E., Kim, G.J., Miller, L.C., Taur, Y., Protective factors in the intestinal microbiome against clostridium difficile infection in recipients of allogeneic hematopoietic stem cell transplantation. J. Infect. Dis., 1, 2017, 10.1093/infdis/jix011.
104. Paramsothy, S., Kamm, M.A., Kaakoush, N.O., Walsh, A.J., van den Bogaerde, J., Samuel, D., Borody, T.J., Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389:10075 (2017), 1218–1228, 10.1016/S0140-6736(17)30182-4.
105. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:7122 (2006), 1027–1031, 10.1038/nature05414.
106. Singh, H., Nugent, Z., Yu, B.N., Lix, L.M., Targownik, L.E., Bernstein, C.N., Higher incidence of clostridium difficile infection among individuals with inflammatory bowel disease. Gastroenterology, 2017, 10.1053/j.gastro.2017.04.044.
107. Hebbard, A.I.T., Slavin, M.A., Reed, C., Trubiano, J.A., Teh, B.W., Haeusler, G.M., Worth, L.J., Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study. Support Care Cancer 25:6 (2017), 1923–1930, 10.1007/s00520-017-3606-y.
108. Taur, Y., Pamer, E.G., Microbiome mediation of infections in the cancer setting. Genome Med., 8(1), 2016, 40, 10.1186/s13073-016-0306-z.
109. Hill, D.A., Artis, D., Intestinal bacteria and the regulation of immune cell homeostasis. Annu. Rev. Immunol. 28 (2010), 623–667, 10.1146/annurev-immunol-030409-101330.
110. Bordon, Y., Tumour immunology: microbiota predicts side-effects of immunotherapy. Nat. Rev. Immunol. 16:3 (2016), 130–131, 10.1038/nri.2016.22.
111. Dubin, K., Callahan, M.K., Ren, B., Khanin, R., Viale, A., Ling, L., Wolchok, Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat. Commun., 7, 2016, 10391, 10.1038/ncomms10391.
112. Vetizou, M., Pitt, J.M., Daillere, R., Lepage, P., Waldschmitt, N., Flament, C., Zitvogel, L., Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350:6264 (2015), 1079–1084, 10.1126/science.aad1329.
113. Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., Gajewski, T.F., Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350:6264 (2015), 1084–1089, 10.1126/science.aac4255.
114. Eiseman, B., Silen, W., Bascom, G.S., Kauvar, A.J., Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44:5 (1958), 854–859.
115. Story, M., Neumark-Sztainer, D., French, S., Individual and environmental influences on adolescent eating behaviors. J. Am. Diet. Assoc. 102:Suppl. 3 (2002), S40–51.
116. Qaim, M., Globalisation of agrifood systems and sustainable nutrition. Proc. Nutr. Soc. 76:1 (2017), 12–21, 10.1017/S0029665116000598.
117. McMichael, P., The impact of globalisation, free trade and technology on food and nutrition in the new millennium. Proc. Nutr. Soc. 60:2 (2001), 215–220.
118. Cabello, F.C., Godfrey, H.P., Buschmann, A.H., Dolz, H.J., Aquaculture as yet another environmental gateway to the development and globalisation of antimicrobial resistance. Lancet Infect. Dis. 16:7 (2016), e127–133, 10.1016/S1473-3099(16)00100-6.
119. Robertson, L.J., Sprong, H., Ortega, Y.R., van der Giessen, J.W., Fayer, R., Impacts of globalisation on foodborne parasites. Trends Parasitol. 30:1 (2014), 37–52, 10.1016/j.pt.2013.09.005.
120. Nowak-Wegrzyn, A., Szajewska, H., Lack, G., Food allergy and the gut. Nat. Rev. Gastroenterol. Hepatol. 14:4 (2017), 241–257, 10.1038/nrgastro.2016.187.
121. Kaplan, G.G., Ng, S.C., Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol. Hepatol. 1:4 (2016), 307–316, 10.1016/S2468-1253(16)30077-2.
122. Alberdi, A., Aizpurua, O., Bohmann, K., Zepeda-Mendoza, M.L., Gilbert, M.T., Do vertebrate gut metagenomes confer rapid ecological adaptation?. Trends Ecol. Evol. 31:9 (2016), 689–699, 10.1016/j.tree.2016.06.008.
123. Davies, J., The business case for soil. Nature 543:7645 (2017), 309–311, 10.1038/543309a.
124. Dalin, C., Wada, Y., Kastner, T., Puma, M.J., Groundwater depletion embedded in international food trade. Nature 543:7647 (2017), 700–704, 10.1038/nature21403.
125. Martens, E.C., Lowe, E.C., Chiang, H., Pudlo, N.A., Wu, M., McNulty, N.P., Gordon, J.I., Recognition and degradation of plant cell wall polysaccharides by two human gut symbionts. PLoS Biol., 9(12), 2011, e1001221, 10.1371/journal.pbio.1001221.
126. Gould, J., Nutrition: a world of insecurity. Nature 544:7651 (2017), S6–S7, 10.1038/544s6a.
127. McDermott, J., Wyatt, A.J., The role of pulses in sustainable and healthy food systems. Ann. N. Y. Acad. Sci. 1392:1 (2017), 30–42, 10.1111/nyas.13319.
128. Schneider, G., Schmidt-Supprian, M., Rad, R., Saur, D., Tissue-specific tumorigenesis: context matters. Nat. Rev. Cancer 17:4 (2017), 239–253, 10.1038/nrc.2017.5.
129. Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Segal, E., Personalized nutrition by prediction of glycemic responses. Cell 163:5 (2015), 1079–1094, 10.1016/j.cell.2015.11.001.
130. Rock, C.L., Doyle, C., Demark-Wahnefried, W., Meyerhardt, J., Courneya, K.S., Schwartz, A.L., Gansler, T., Nutrition and physical activity guidelines for cancer survivors. CA Cancer J. Clin. 62:4 (2012), 243–274, 10.3322/caac.21142.
131. Baldwin, C., Spiro, A., Ahern, R., Emery, P.W., Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J. Natl. Cancer Inst. 104:5 (2012), 371–385, 10.1093/jnci/djr556.
132. Campbell, T.C., The past, present, and future of nutrition and cancer: part 1-Was a nutritional association acknowledged a century ago?. Nutr. Cancer, 1–7, 2017, 10.1080/01635581.2017.1317823.
133. Mayne, S.T., Playdon, M.C., Rock, C.L., Diet, nutrition, and cancer: past, present and future. Nat. Rev. Clin. Oncol. 13:8 (2016), 504–515, 10.1038/nrclinonc.2016.24.
134. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., Lewis, J.D., Linking long-term dietary patterns with gut microbial enterotypes. Science 334:6052 (2011), 105–108, 10.1126/science.1208344.
135. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Turnbaugh, P.J., Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:7484 (2014), 559–563, 10.1038/nature12820.
136. Hibberd, M.C., Wu, M., Rodionov, D.A., Li, X., Cheng, J., Griffin, N.W., Gordon, J.I., The effects of micronutrient deficiencies on bacterial species from the human gut microbiota. Sci. Transl. Med., 9(390), 2017, 10.1126/scitranslmed.aal4069.
137. David, L.A., Materna, A.C., Friedman, J., Campos-Baptista, M.I., Blackburn, M.C., Perrotta, A., Alm, E.J., Host lifestyle affects human microbiota on daily timescales. Genome Biol., 15(7), 2014, R89, 10.1186/gb-2014-15-7-r89.
138. Carmody, R.N., Gerber, G.K., Luevano, J.M. Jr., Gatti, D.M., Somes, L., Svenson, K.L., Turnbaugh, P.J., Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe 17:1 (2015), 72–84, 10.1016/j.chom.2014.11.010.
139. Turnbaugh, P.J., Ridaura, V.K., Faith, J.J., Rey, F.E., Knight, R., Gordon, J.I., The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med., 1(6), 2009, 6ra14, 10.1126/scitranslmed.3000322.
140. Wu, M., McNulty, N.P., Rodionov, D.A., Khoroshkin, M.S., Griffin, N.W., Cheng, J., Gordon, J.I., Genetic determinants of in vivo fitness and diet responsiveness in multiple human gut Bacteroides. Science, 2015, ac5992, 10.1126/science.aac5992.
141. Griffin, N.W., Ahern, P.P., Cheng, J., Heath, A.C., Ilkayeva, O., Newgard, C.B., Gordon, J.I., Prior dietary practices and connections to a human gut microbial metacommunity alter responses to diet interventions. Cell Host Microbe 21:1 (2017), 84–96, 10.1016/j.chom.2016.12.006.
142. Macpherson, A.J., McCoy, K.D., Standardised animal models of host microbial mutualism. Mucosal Immunol. 8:3 (2015), 476–486, 10.1038/mi.2014.113.
143. Tomasetti, C., Vogelstein, B., Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347:6217 (2015), 78–81, 10.1126/science.1260825.
144. Blokzijl, F., de Ligt, J., Jager, M., Sasselli, V., Roerink, S., Sasaki, N., van Boxtel, R., Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538:7624 (2016), 260–264, 10.1038/nature19768.
145. Pope, J.L., Tomkovich, S., Yang, Y., Jobin, C., Microbiota as a mediator of cancer progression and therapy. Transl. Res. 179 (2017), 139–154, 10.1016/j.trsl.2016.07.021.
146. Spor, A., Koren, O., Ley, R., Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9:4 (2011), 279–290, 10.1038/nrmicro2540.